Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · IEX Real-Time Price · USD
0.707
-0.019 (-2.66%)
At close: May 2, 2024, 4:00 PM
0.720
+0.013 (1.81%)
After-hours: May 2, 2024, 7:59 PM EDT

Citius Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Year Current2023202220212020201920182017201620152013
Market Capitalization
12810917729658172826---
Market Cap Growth
--38.51%-40.33%413.63%245.02%-39.63%6.47%----
Enterprise Value
1088313622745919230-13
PE Ratio
-3.06-3.23-5.26-12.09-3.29-1.07-2.21-2.50---
PB Ratio
1.511.201.722.241.710.620.991.19---
P/FCF Ratio
-3.96-3.74-6.23-12.22-3.41-1.34-2.45-3.26---
P/OCF Ratio
-3.96-3.74-6.23-12.22-3.41-1.34-2.45-3.26---
EV/EBITDA Ratio
-2.68-2.60-4.13-9.93-2.60-0.58-1.49-2.41-0.050.23-2.18
EV/EBIT Ratio
-2.67-2.59-4.11-9.85-2.57-0.58-1.49-2.41-0.050.23-2.18
EV/FCF Ratio
-3.30-2.85-4.79-9.36-2.67-0.72-1.65-2.88-0.060.28-2.36
Debt / Equity Ratio
0.010.010.010.010.040.010.010.010.04--0.91
Debt / EBITDA Ratio
-0.01-0.02-0.02-0.04-0.08-0.01-0.01-0.02-0.08--2.23
Debt / FCF Ratio
-0.01-0.02-0.02-0.04-0.08-0.01-0.02-0.02-0.11--2.41
Quick Ratio
3.654.599.2217.613.401.733.141.300.060.490.04
Current Ratio
5.065.959.8418.293.411.723.161.390.170.540.08
Interest Coverage
----2125.99-1118.64-945.43-790.55-11.21-921.36-385.97-11.21
Return on Equity (ROE)
-43.20%-35.50%-29.60%-23.40%-66.70%-66.40%-50.70%-66.30%-61.70%326.30%-
Return on Assets (ROA)
-37.90%-31.30%-26.90%-21.40%-52.50%-54.30%-45.80%-46.80%-47.30%-352.60%-
Return on Capital (ROIC)
-45.59%-40.23%-32.19%-17.69%-50.57%-57.08%-49.18%-45.15%-42.72%508.48%443.30%
Earnings Yield
-30.82%-30.99%-19.03%-8.27%-30.42%-93.06%-45.26%-39.91%---
FCF Yield
-23.80%-26.73%-16.04%-8.19%-29.35%-74.38%-40.86%-30.65%---
Buyback Yield / Dilution
-8.72%-3.57%-34.52%-177.28%-94.25%-87.87%-95.75%-51.32%-70.72%-79.27%-5.15%
Total Shareholder Return
-8.72%-3.57%-34.52%-177.28%-94.25%-87.87%-95.75%-51.32%-70.72%-79.27%-5.15%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).